Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR)

CUSIP: 57055L107

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock, Par Value $0.001
Shares outstanding
12,939,536
Total 13F shares
17,136,981
Share change
+272,069
Total reported value
$87,562,375
Put/Call ratio
58%
Price per share
$5.11
Number of holders
71
Value change
-$1,565,828
Number of buys
39
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 57055L107?
CUSIP 57055L107 identifies MRKR - Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) as of Q3 2019

As of 30 Sep 2019, Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,136,981 shares. The largest 10 holders included NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, Aisling Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and MARSHALL WACE, LLP. This page lists 71 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.